Kyle Patrick, D.O.
Dedicated Phase I
1
1
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Iris-Tatjana Kolassa, Prof. Dr.
Clinical and Biological Psychology, University of Ulm
Shared therapeutic areas:
Eric Powell, PhD
Clayton Sleep Institute
Shared therapeutic areas:
Ashley I. Bush
The Florey Institute of Neuroscience and Mental Health
Shared therapeutic areas:
Susan Y Bookheimer, PhD
UCLA Psychiatry & Biobehavioral Sciences
Shared therapeutic areas:
John Stoukides, MD
Medical Director, Rhode Island Mood & Memory Research Institute
Shared therapeutic areas:
Robert Hernandez, Ph.D.
High Point Pharmaceuticals, LLC.
Shared therapeutic areas:
Robert C. Alexander, MD
AstraZeneca Research & Development, Neuroscience iMed, 141 Portland Street, Cambridge, MA 02139
Shared therapeutic areas:
Paula Grammas, PhD
Executive Director of the Ryan Institute for Neuroscience
Shared therapeutic areas:
Hesheng Liu, Ph.D.
Changping Laboratory
Shared therapeutic areas:
James Patterson, MD PhD
Louisiana State University Health Sciences Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease
All 1 trials loaded